Frances C Hall
Affiliation: University of Cambridge
- The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's SyndromeSarah Brown
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS2 9JT, UK
BMC Musculoskelet Disord 15:21. 2014..For patients with PSS there is currently no effective therapy that can alter the progression of the disease. The aim of the TRACTISS study is to establish whether in patients with PSS, treatment with rituximab improves clinical outcomes...
- Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndromeRobert Busch
Division of Rheumatology, Department of Medicine, University of Cambridge, Cambridge, UK
Curr Pharm Biotechnol 13:2009-21. 2012..A better understanding of T-cell dysregulation in PSS is required in order to understand its contribution to disease, aid prognosis, and improve therapeutic interventions aimed at this aspect of the disease...
- Put your heart into the joint benefits of statins!Frances C Hall
ARC Rheumatology Lecturer, Addenbrooke s Hospital, Cambridge, UK
Arthritis Res Ther 5:202-4. 2003
- Cold hands--strained heart? Advances in the management of Raynaud's phenomenon and pulmonary hypertensionFrances C Hall
University of Cambridge School of Clinical Medicine, Addenbrooke s Hospital, Cambridge, UK
Arthritis Res Ther 7:126-8. 2005
- Disease modification and cardiovascular risk reduction: two sides of the same coin?F C Hall
University of Cambridge School of Medicine, UK
Rheumatology (Oxford) 44:1473-82. 2005..Long-term studies of such interventions are needed to further clarify the benefits of intensive cardiovascular risk management in these patients...
- Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritisKaisa M Maki-Petaja
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom
J Am Coll Cardiol 50:852-8. 2007..The aim of this study was to investigate the effect of simvastatin and ezetimibe on inflammation, disease activity, endothelial dysfunction, and arterial stiffness in a cohort of rheumatoid arthritis (RA) patients...
- Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunctionKaisa M Maki-Petaja
Clinical Pharmacology Unit, University of Cambridge, Addenbrooke s Hospital, Box 110, Cambridge, UK
Int J Cardiol 129:399-405. 2008..The aim of the study was to establish the contribution of iNOS to endothelial function...
- Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapyKaisa M Maki-Petaja
Clinical Pharmacology Unit, University of Cambridge, Addenbrooke s Hospital, Box 110, Cambridge CB2 2QQ, United Kingdom
Circulation 114:1185-92. 2006..In addition, we tested the hypothesis that aortic stiffness could be reduced with anti-tumor necrosis factor-alpha (TNF-alpha) therapy...
- Targeting CVD risk in chronic connective tissue diseaseAnshuman P Malaviya
Rheumatology Clinical Research Unit, Addenbrooke s Hospital, Cambridge
Practitioner 256:21-6, 3. 2012..Atherogenesis in the context of autoimmune disease results from a complex interplay between traditional risk factors, disease-specific factors and drug-related adverse effects. Chronic inflammation itself modifies the lipid profile...